First-in-man treatment of a degenerated mitral surgical valve with the mechanical expanding Lotus™ valve.
Percutaneous placement of transcatheter heart valves for treatment of degenerated surgical valves in the aortic and mitral position is an emerging therapy for selected high-risk patients. Here we describe in detail the first case in the literature of a patient (female, 72 years old, log EuroSCORE 22.9%) with a degenerated biological mitral prosthesis which was successfully treated by transapical implantation of a Lotus valve. The case described demonstrates the very controlled feasibility of valve-in-valve treatment for a degenerated mitral bioprosthesis with a mechanically expanding Lotus valve.
Division of Cardiology, University Heart Center Eppendorf, Hamburg, Germany.
Ulrich
U
Schaefer
Lenard
L
Conradi
Edith
E
Lubos
Florian
F
Deuschl
Niklas
N
Schofer
Hendrik
H
Treede
Johannes
J
Schirmer
Beatrice
B
Vogel
Hermann
H
Reichenspurner
Stefan
S
Blankenberg
D001705:Bioprosthesis / Q000009:adverse effects; D005260:Female; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects; D006801:Humans; D008943:Mitral Valve / Q000000981:diagnostic imaging / Q000601:surgery*; D008944:Mitral Valve Insufficiency / Q000175:diagnosis / Q000601:surgery*; D011474:Prosthesis Design; D012307:Risk Factors; D016896:Treatment Outcome; D014656:Vascular Surgical Procedures